Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
6.64
-0.04 (-0.52%)
Sep 24, 2026, 10:49 AM EDT - Market open
Emergent BioSolutions Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 770.2 | 742.9 | 1,044 | 1,049 | 1,118 | 1,774 |
Revenue Growth | -9.56% | -28.81% | -0.54% | -6.10% | -36.99% | 12.45% |
Gross Profit Gross Profit Growth | 388.5 | 367.3 | 311.6 | 254.2 | 290.1 | 793.2 |
Operating Income Operating Income Growth | 140.5 | 115.6 | -52.2 | -168.1 | -109.3 | 386 |
Net Income Net Income Growth | -176.8 | 52.6 | -190.6 | -760.5 | -211.6 | 219.5 |
Earnings Per Share EPS Growth | -3.39 | 0.93 | -3.60 | -14.85 | -4.22 | 4.06 |
EPS Growth | - | - | - | - | - | -28.52% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Commercial Products Commercial Products Growth | 208.6 | 226.1 | 398.9 | 497.3 | 386.6 | 438 |
Mcm Products Mcm Products Growth | 511.5 | 456.7 | 509.8 | 447.2 | 579.6 | 585.9 |
Other Other Growth | 50.1 | 60.1 | 134.9 | 104.8 | - | - |
Total Total Growth | 770.2 | 742.9 | 1,044 | 1,049 | 1,118 | 1,774 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 139.7 | 205.4 | 99.5 | 111.7 | 651.1 | 576.1 |
Total Debt Total Debt Growth | 588.2 | 583.7 | 676.1 | 877.5 | 1,426 | 877.1 |
Net Cash (Debt) Net Cash Growth | -448.5 | -378.3 | -576.6 | -765.8 | -775.3 | -301 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -8.59 | -6.67 | -10.88 | -14.96 | -15.48 | -5.56 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 97.7 | 170.6 | 58.7 | -206.3 | -34.1 | 320.2 |
Capital Expenditures CapEx Growth | -11.8 | -13.8 | -22.9 | -51.6 | -115.8 | -224.1 |
Free Cash Flow Free Cash Flow Growth | 85.9 | 156.8 | 35.8 | -257.9 | -149.9 | 96.1 |
Free Cash Flow Growth | -44.58% | 337.99% | - | - | - | -75.67% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 50.44% | 49.44% | 29.86% | 24.23% | 25.96% | 44.72% |
Operating Margin | 18.24% | 15.56% | -5.00% | -16.02% | -9.78% | 21.76% |
Pretax Margin | -18.96% | 11.15% | -13.69% | -69.68% | -19.60% | 17.10% |
Profit Margin | -22.96% | 7.08% | -18.26% | -72.48% | -18.93% | 12.38% |
FCF Margin | 11.15% | 21.11% | 3.43% | -24.58% | -13.41% | 5.42% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 12.34 | - | - | - | 10.65 |
Forward PE | - | 4.16 | 12.57 | 20.50 | 51.15 | 7.19 |
P/FCF Ratio | 3.98 | 4.14 | 14.47 | - | - | 24.34 |
PS Ratio | 0.44 | 0.87 | 0.50 | 0.12 | 0.53 | 1.32 |